Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Primary T cells from cutaneous T-cell lymphoma skin explants display an exhausted immune checkpoint profile.

Querfeld C, Leung S, Myskowski PL, Curran SA, Goldman DA, Heller G, Wu X, Kil SH, Sharma S, Finn KJ, Horwitz S, Moskowitz A, Mehrara B, Rosen ST, Halpern AC, Young JW.

Cancer Immunol Res. 2018 Jun 12. pii: canimm.0270.2017. doi: 10.1158/2326-6066.CIR-17-0270. [Epub ahead of print]

PMID:
29895574
2.

Multi-kinase inhibitor with anti-p38γ activity in cutaneous T cell lymphoma.

Zhang XH, Nam S, Wu J, Chen CH, Liu X, Li H, McKeithan T, Gong Q, Chan WC, Yin HH, Yuan YC, Pillai R, Querfeld C, Horne D, Chen Y, Rosen ST.

J Invest Dermatol. 2018 May 11. pii: S0022-202X(18)31967-5. doi: 10.1016/j.jid.2018.04.030. [Epub ahead of print]

PMID:
29758280
3.

The Use of Central Pathology Review With Digital Slide Scanning in Advanced-stage Mycosis Fungoides and Sézary Syndrome: A Multi-institutional and International Pathology Study.

Gru AA, Kim J, Pulitzer M, Guitart J, Battistella M, Wood GS, Cerroni L, Kempf W, Willemze R, Pawade J, Querfeld C, Schaffer A, Pincus L, Tetzlaff M, Duvic M, Scarisbrick J, Porcu P, Mangold AR, DiCaudo DJ, Shinohara M, Hong EK, Horton B, Kim YH.

Am J Surg Pathol. 2018 Jun;42(6):726-734. doi: 10.1097/PAS.0000000000001041.

PMID:
29543675
4.

Progression of undiagnosed cutaneous lymphoma after anti-tumor necrosis factor-alpha therapy.

Martinez-Escala ME, Posligua AL, Wickless H, Rutherford A, Sable KA, Rubio-Gonzalez B, Zhou XA, Kaplan JB, Pro B, Choi J, Querfeld C, Rosen ST, Guitart J.

J Am Acad Dermatol. 2018 Jun;78(6):1068-1076. doi: 10.1016/j.jaad.2017.12.068. Epub 2018 Jan 4.

PMID:
29307643
5.

Clinical Outcome and Prognosis of Young Patients with Mycosis Fungoides.

Virmani P, Levin L, Myskowski PL, Flores E, Marchetti MA, Lucas AS, Pulitzer M, Horwitz S, Trippett T, Moskowitz A, Querfeld C.

Pediatr Dermatol. 2017 Sep;34(5):547-553. doi: 10.1111/pde.13226. Epub 2017 Aug 14.

PMID:
28804919
6.

Clinical manifestations and pathogenesis of cutaneous lymphomas: current status and future directions.

Rubio-Gonzalez B, Zain J, Rosen ST, Querfeld C.

Br J Haematol. 2017 Jan;176(1):16-36. doi: 10.1111/bjh.14402. Epub 2016 Oct 26. Review.

PMID:
27782301
7.

An Elderly Man With New Skin Plaques Consistent With Cutaneous T-Cell Lymphoma.

Rubio-González B, Zain J, Rosen ST, Querfeld C.

Oncology (Williston Park). 2016 Oct 15;30(10):908-13. No abstract available.

8.

Cutaneous Gamma-Delta T-Cell Lymphoma Successfully Treated With Brentuximab Vedotin.

Rubio-Gonzalez B, Zain J, Garcia L, Rosen ST, Querfeld C.

JAMA Dermatol. 2016 Dec 1;152(12):1388-1390. doi: 10.1001/jamadermatol.2016.3117. No abstract available.

PMID:
27653662
9.

Pembrolizumab-associated sarcoidosis.

Cotliar J, Querfeld C, Boswell WJ, Raja N, Raz D, Chen R.

JAAD Case Rep. 2016 Jul 27;2(4):290-3. doi: 10.1016/j.jdcr.2016.06.004. eCollection 2016 Jul. No abstract available.

10.

Long-term follow-up and management of small and medium-sized CD4+ T cell lymphoma and CD8+ lymphoid proliferations of acral sites: a multicenter experience.

Virmani P, Jawed S, Myskowski PL, Horwitz S, Skripnik Lucas A, Moskowitz A, Pulitzer M, Zain J, Rosen ST, Querfeld C.

Int J Dermatol. 2016 Nov;55(11):1248-1254. doi: 10.1111/ijd.13340.

11.

Reflectance confocal microscopy features of mycosis fungoides and Sézary syndrome: correlation with histopathologic and T-cell receptor rearrangement studies.

Mancebo SE, Cordova M, Myskowski PL, Flores ES, Busam K, Jawed SI, Skripnik A, Rajadhyaksha M, Querfeld C.

J Cutan Pathol. 2016 Jun;43(6):505-15. doi: 10.1111/cup.12708. Epub 2016 Apr 8.

12.

Autoimmune Bullous Skin Disorders with Immune Checkpoint Inhibitors Targeting PD-1 and PD-L1.

Naidoo J, Schindler K, Querfeld C, Busam K, Cunningham J, Page DB, Postow MA, Weinstein A, Lucas AS, Ciccolini KT, Quigley EA, Lesokhin AM, Paik PK, Chaft JE, Segal NH, D'Angelo SP, Dickson MA, Wolchok JD, Lacouture ME.

Cancer Immunol Res. 2016 May;4(5):383-9. doi: 10.1158/2326-6066.CIR-15-0123. Epub 2016 Feb 29.

13.

Tumor microenvironment in mycosis fungoides and Sézary syndrome.

Rubio Gonzalez B, Zain J, Rosen ST, Querfeld C.

Curr Opin Oncol. 2016 Jan;28(1):88-96. doi: 10.1097/CCO.0000000000000243. Review.

PMID:
26632770
14.

Graft-versus-host disease-like erythroderma: a manifestation of thymoma-associated multiorgan autoimmunity.

Warren S, Nehal K, Querfeld C, Wong R, Huang J, Pulitzer M.

J Cutan Pathol. 2015 Oct;42(10):663-8. doi: 10.1111/cup.12642. No abstract available.

15.

Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model.

Scarisbrick JJ, Prince HM, Vermeer MH, Quaglino P, Horwitz S, Porcu P, Stadler R, Wood GS, Beylot-Barry M, Pham-Ledard A, Foss F, Girardi M, Bagot M, Michel L, Battistella M, Guitart J, Kuzel TM, Martinez-Escala ME, Estrach T, Papadavid E, Antoniou C, Rigopoulos D, Nikolaou V, Sugaya M, Miyagaki T, Gniadecki R, Sanches JA, Cury-Martins J, Miyashiro D, Servitje O, Muniesa C, Berti E, Onida F, Corti L, Hodak E, Amitay-Laish I, Ortiz-Romero PL, Rodríguez-Peralto JL, Knobler R, Porkert S, Bauer W, Pimpinelli N, Grandi V, Cowan R, Rook A, Kim E, Pileri A, Patrizi A, Pujol RM, Wong H, Tyler K, Stranzenbach R, Querfeld C, Fava P, Maule M, Willemze R, Evison F, Morris S, Twigger R, Talpur R, Kim J, Ognibene G, Li S, Tavallaee M, Hoppe RT, Duvic M, Whittaker SJ, Kim YH.

J Clin Oncol. 2015 Nov 10;33(32):3766-73. doi: 10.1200/JCO.2015.61.7142. Epub 2015 Oct 5.

16.

Jejunal adenocarcinoma with cutaneous metastasis.

Chung E, Syklawer E, Pulitzer MP, Marchetti MA, Querfeld C, Myskowski PL.

Dermatol Online J. 2015 Jul 15;21(7). pii: 13030/qt2fh785fw.

PMID:
26436979
17.

Hematopoietic Stem Cell Transplant for Mycosis Fungoides and Sézary Syndrome.

Virmani P, Zain J, Rosen ST, Myskowski PL, Querfeld C.

Dermatol Clin. 2015 Oct;33(4):807-18. doi: 10.1016/j.det.2015.05.014. Epub 2015 Jul 29. Review.

18.

Histopathologic Features of Cutaneous Acute Graft-Versus-Host Disease in T-Cell-Depleted Peripheral Blood Stem Cell Transplant Recipients.

Fischer A, Jakubowski AA, Lacouture ME, Hollmann TJ, Drucker AM, Maloy M, Prockop S, Querfeld C, Busam KJ, Pulitzer MP.

Am J Dermatopathol. 2015 Jul;37(7):523-9. doi: 10.1097/DAD.0000000000000357.

19.

Management of advanced cutaneous T-cell lymphoma: role of the dermatologist in the multidisciplinary team.

Poligone B, Querfeld C.

Br J Dermatol. 2015 Oct;173(4):1081-3. doi: 10.1111/bjd.13849. Epub 2015 Aug 27. No abstract available.

20.

Ten-year pruritic eruption in a Japanese man.

Mancebo SE, Busam KJ, Querfeld C.

Int J Dermatol. 2015 Jun;54(6):635-6. doi: 10.1111/ijd.12873. Epub 2015 Mar 17. No abstract available.

PMID:
25783175
21.

Cutaneous manifestations of human T-cell lymphotrophic virus type-1-associated adult T-cell leukemia/lymphoma: a single-center, retrospective study.

Marchetti MA, Pulitzer MP, Myskowski PL, Dusza SW, Lunning MA, Horwitz SM, Moskowitz AJ, Querfeld C.

J Am Acad Dermatol. 2015 Feb;72(2):293-301. doi: 10.1016/j.jaad.2014.10.006. Epub 2014 Nov 8.

PMID:
25455841
22.

Mycosis fungoides with large cell transformation: clinicopathological features and prognostic factors.

Pulitzer M, Myskowski PL, Horwitz SM, Querfeld C, Connolly B, Li J, Murali R.

Pathology. 2014 Dec;46(7):610-6. doi: 10.1097/PAT.0000000000000166.

23.

Cutaneous hemophagocytosis after alemtuzumab injection in a patient with Sézary syndrome.

Jawed SI, Busam K, Wang X, Horwitz S, Querfeld C.

JAMA Dermatol. 2014 Sep;150(9):1021-3. doi: 10.1001/jamadermatol.2013.10615. No abstract available.

PMID:
25029560
24.

A case of protothecosis in a patient with multiple myeloma.

Figueroa CJ, Camp BJ, Varghese GI, Miranda E, Querfeld C, Hassoun H, Kamboj M, Pulitzer MP.

J Cutan Pathol. 2014 May;41(5):409-13. doi: 10.1111/cup.12338. No abstract available.

PMID:
24758253
25.

Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.

Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C.

J Am Acad Dermatol. 2014 Feb;70(2):223.e1-17; quiz 240-2. doi: 10.1016/j.jaad.2013.08.033. Review.

PMID:
24438970
26.

Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.

Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C.

J Am Acad Dermatol. 2014 Feb;70(2):205.e1-16; quiz 221-2. doi: 10.1016/j.jaad.2013.07.049. Review.

PMID:
24438969
27.

Multicenter case series of indolent small/medium-sized CD8+ lymphoid proliferations with predilection for the ear and face.

Li JY, Guitart J, Pulitzer MP, Subtil A, Sundram U, Kim Y, Deonizio J, Myskowski PL, Moskowitz A, Horwitz S, Querfeld C.

Am J Dermatopathol. 2014 May;36(5):402-8. doi: 10.1097/DAD.0b013e3182a74c7a.

PMID:
24394306
28.

Results of an open-label multicenter phase 2 trial of lenalidomide monotherapy in refractory mycosis fungoides and Sézary syndrome.

Querfeld C, Rosen ST, Guitart J, Duvic M, Kim YH, Dusza SW, Kuzel TM.

Blood. 2014 Feb 20;123(8):1159-66. doi: 10.1182/blood-2013-09-525915. Epub 2013 Dec 11.

29.

Disseminated mantle-cell lymphoma presenting as a petechial maculopapular eruption.

Jawed SI, Hollmann TJ, Moskowitz CH, Desman G, Querfeld C.

JAMA Dermatol. 2014 Jan;150(1):94-6. doi: 10.1001/jamadermatol.2013.5388. No abstract available.

PMID:
24258452
30.

Primary cutaneous B-cell lymphomas: part II. Therapy and future directions.

Suárez AL, Querfeld C, Horwitz S, Pulitzer M, Moskowitz A, Myskowski PL.

J Am Acad Dermatol. 2013 Sep;69(3):343.e1-11; quiz 355-6. doi: 10.1016/j.jaad.2013.06.011. Review.

PMID:
23957985
31.

Primary cutaneous B-cell lymphomas: part I. Clinical features, diagnosis, and classification.

Suárez AL, Pulitzer M, Horwitz S, Moskowitz A, Querfeld C, Myskowski PL.

J Am Acad Dermatol. 2013 Sep;69(3):329.e1-13; quiz 341-2. doi: 10.1016/j.jaad.2013.06.012. Review.

PMID:
23957984
32.

A case-control study of clinicopathologic features, prognosis, and therapeutic responses in patients with granulomatous mycosis fungoides.

Li JY, Pulitzer MP, Myskowski PL, Dusza SW, Horwitz S, Moskowitz A, Querfeld C.

J Am Acad Dermatol. 2013 Sep;69(3):366-74. doi: 10.1016/j.jaad.2013.03.036. Epub 2013 May 16.

PMID:
23685027
33.

Long-term follow-up and survival of cutaneous T-cell lymphoma patients treated with extracorporeal photopheresis.

Knobler R, Duvic M, Querfeld C, Straus D, Horwitz S, Zain J, Foss F, Kuzel T, Campbell K, Geskin L.

Photodermatol Photoimmunol Photomed. 2012 Oct;28(5):250-7. doi: 10.1111/j.1600-0781.2012.00689.x.

PMID:
22971190
34.

Outcome of patients treated with a single-fraction dose of palliative radiation for cutaneous T-cell lymphoma.

Thomas TO, Agrawal P, Guitart J, Rosen ST, Rademaker AW, Querfeld C, Hayes JP, Kuzel TM, Mittal BB.

Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):747-53. doi: 10.1016/j.ijrobp.2012.05.034. Epub 2012 Jul 17.

PMID:
22818412
35.

Management of cutaneous T cell lymphoma: new and emerging targets and treatment options.

Li JY, Horwitz S, Moskowitz A, Myskowski PL, Pulitzer M, Querfeld C.

Cancer Manag Res. 2012;4:75-89. doi: 10.2147/CMAR.S9660. Epub 2012 Mar 12.

36.

Cutaneous T-cell lymphomas: a review of new discoveries and treatments.

Bloom T, Kuzel TM, Querfeld C, Guitart J, Rosen ST.

Curr Treat Options Oncol. 2012 Mar;13(1):102-21. doi: 10.1007/s11864-011-0179-8. Review.

PMID:
22311555
37.

Local lymph node micrometastasis in a patient with negative sentinel lymph node biopsies after lymphatic mapping with wide local excision of primary melanoma on the head/neck area.

Querfeld C, Wayne JD, Wei JJ, Abdul-Nabi A, Gerami P.

Am J Dermatopathol. 2011 Oct;33(7):745-8. doi: 10.1097/DAD.0b013e31820977f1.

PMID:
21946765
38.

Sorafenib-induced eruption resembling pityriasis rubra pilaris.

Paz C, Querfeld C, Shea CR.

J Am Acad Dermatol. 2011 Aug;65(2):452-3. doi: 10.1016/j.jaad.2010.03.015. No abstract available.

PMID:
21763585
39.

Multicenter phase II trial of temozolomide in mycosis fungoides/sezary syndrome: correlation with O⁶-methylguanine-DNA methyltransferase and mismatch repair proteins.

Querfeld C, Rosen ST, Guitart J, Rademaker A, Pezen DS, Dolan ME, Baron J, Yarosh DB, Foss F, Kuzel TM.

Clin Cancer Res. 2011 Sep 1;17(17):5748-54. doi: 10.1158/1078-0432.CCR-11-0556. Epub 2011 Jul 11.

40.

Multicenter phase II trial of enzastaurin in patients with relapsed or refractory advanced cutaneous T-cell lymphoma.

Querfeld C, Kuzel TM, Kim YH, Porcu P, Duvic M, Musiek A, Rook AH, Mark LA, Pinter-Brown L, Hamid O, Lin B, Bian Y, Boye M, Day JM, Rosen ST.

Leuk Lymphoma. 2011 Aug;52(8):1474-80. doi: 10.3109/10428194.2011.572265. Epub 2011 Jun 8.

PMID:
21649541
41.

Disseminated follicular eruption during therapy with the MEK inhibitor AZD6244.

Querfeld C, Duffy K, Magel G, Oble D, Cohen EE, Shea CR.

J Am Acad Dermatol. 2011 Feb;64(2):e17-9. doi: 10.1016/j.jaad.2009.06.070. No abstract available.

PMID:
21238821
42.

Sézary syndrome: immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC).

Olsen EA, Rook AH, Zic J, Kim Y, Porcu P, Querfeld C, Wood G, Demierre MF, Pittelkow M, Wilson LD, Pinter-Brown L, Advani R, Parker S, Kim EJ, Junkins-Hopkins JM, Foss F, Cacchio P, Duvic M.

J Am Acad Dermatol. 2011 Feb;64(2):352-404. doi: 10.1016/j.jaad.2010.08.037. Epub 2010 Dec 9. Review.

PMID:
21145619
43.

Primary cutaneous and systemic anaplastic large cell lymphoma: clinicopathologic aspects and therapeutic options.

Querfeld C, Khan I, Mahon B, Nelson BP, Rosen ST, Evens AM.

Oncology (Williston Park). 2010 Jun;24(7):574-87. Review.

44.

Cutaneous involvement with marginal zone lymphoma.

Gerami P, Wickless SC, Querfeld C, Rosen ST, Kuzel TM, Guitart J.

J Am Acad Dermatol. 2010 Jul;63(1):142-5. doi: 10.1016/j.jaad.2009.07.047. Epub 2010 May 11.

PMID:
20462658
45.
46.

Diagnostic and therapeutic challenges of primary cutaneous lymphomas.

Querfeld C.

Oncology (Williston Park). 2009 Nov 30;23(13):1167-8. No abstract available.

47.

Alemtuzumab for relapsed and refractory erythrodermic cutaneous T-cell lymphoma: a single institution experience from the Robert H. Lurie Comprehensive Cancer Center.

Querfeld C, Mehta N, Rosen ST, Guitart J, Rademaker A, Gerami P, Kuzel TM.

Leuk Lymphoma. 2009 Dec;50(12):1969-76. doi: 10.3109/10428190903216770.

PMID:
19860617
48.

Primary cutaneous CD30+ lymphoproliferative disorders: new insights into biology and therapy.

Querfeld C, Kuzel TM, Guitart J, Rosen ST.

Oncology (Williston Park). 2007 May;21(6):689-96; discussion 699-700,. Review.

49.

Phase II trial of subcutaneous injections of human recombinant interleukin-2 for the treatment of mycosis fungoides and Sézary syndrome.

Querfeld C, Rosen ST, Guitart J, Rademaker A, Foss F, Gupta R, Kuzel TM.

J Am Acad Dermatol. 2007 Apr;56(4):580-3. Epub 2006 Nov 7.

PMID:
17367611
50.

Primary cutaneous T-cell lymphomas.

Rosen ST, Querfeld C.

Hematology Am Soc Hematol Educ Program. 2006:323-30, 513. Review.

PMID:
17124079

Supplemental Content

Loading ...
Support Center